Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Ching

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
American Journal of Hematology|July 1, 1993
8;21 translocation and multilineage involvementY L Kwong, L M Ching, H W Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)S-T Woon, S Zwain, M A Schooltink, et al.
British Journal of Cancer|August 1, 1995
Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acidL M Ching, Z F Xu, B H Gummer, et al.
Cancer Genetics and Cytogenetics|September 19, 2000
Translocation (1;13)(p34;q32) in childhood pre-B-cell acute lymphoblastic leukemiaT S Wan, S K Ma, L M Ching, et al.
Cancer Genetics and Cytogenetics|March 25, 2000
Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: resolution by spectral karyotypingT S Wan, S K Ma, G C Chan, et al.
Cancer Genetics and Cytogenetics|February 1, 1997
Cytogenetic abnormalities in pediatric myelodysplastic syndrome: a report of three casesS K Ma, S Y Ha, G C Chan, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomideP Kestell, L Zhao, B C Baguley, et al.
Clinical and Laboratory Haematology|December 21, 2000
Acute myeloid leukaemia with giant granules: association with t(10; 11)(p13; q14) and disseminated intravascular coagulationS K Ma, S F Yip, T S Wan, et al.
Cancer Genetics and Cytogenetics|September 1, 1994
Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong KongL C Chan, S Y Ha, L M Ching, et al.
British Journal of Cancer|March 14, 2013
Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)S M Tijono, K Guo, K Henare, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Hematology|July 1, 1993
8;21 translocation and multilineage involvementY L Kwong, L M Ching, H W Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)S-T Woon, S Zwain, M A Schooltink, et al.
British Journal of Cancer|August 1, 1995
Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acidL M Ching, Z F Xu, B H Gummer, et al.
Cancer Genetics and Cytogenetics|September 19, 2000
Translocation (1;13)(p34;q32) in childhood pre-B-cell acute lymphoblastic leukemiaT S Wan, S K Ma, L M Ching, et al.
Cancer Genetics and Cytogenetics|March 25, 2000
Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: resolution by spectral karyotypingT S Wan, S K Ma, G C Chan, et al.
Cancer Genetics and Cytogenetics|February 1, 1997
Cytogenetic abnormalities in pediatric myelodysplastic syndrome: a report of three casesS K Ma, S Y Ha, G C Chan, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomideP Kestell, L Zhao, B C Baguley, et al.
Clinical and Laboratory Haematology|December 21, 2000
Acute myeloid leukaemia with giant granules: association with t(10; 11)(p13; q14) and disseminated intravascular coagulationS K Ma, S F Yip, T S Wan, et al.
Cancer Genetics and Cytogenetics|September 1, 1994
Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong KongL C Chan, S Y Ha, L M Ching, et al.
British Journal of Cancer|March 14, 2013
Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)S M Tijono, K Guo, K Henare, et al.
Pageof 8